Tisserand D. J., van Boxtel M. P., Pruessner J., Hofman P., Evans A. C., Jolles J. (2004). A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time, Cereb Cortex, 14(9), 966-73.

Trang T., McNaull B., Quirion R., Jhamandas K. (2004). Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance, Eur J Pharmacol, 491(1), 21-30.

Turcotte K., Gauthier S., Mitsos L. M., Shustik C., Copeland N. G., Jenkins N. A., Fournet J. C., Jolicoeur P., Gros P. (2004). Genetic control of myeloproliferation in BXH-2 mice, Blood, 103(6), 2343-50.

Vercauteren F. G., Bergeron J. J., Vandesande F., Arckens L., Quirion R. (2004). Proteomic approaches in brain research and neuropharmacology, Eur J Pharmacol, 500(1-3), 385-398.

Zheng W. H., Quirion R. (2004). Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival, J Neurochem, 89(4), 844-52.

Aleong R., Aumont N., Dea D., Poirier J. (2003). Non-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein, Eur J Neurosci , 18 (6 ), 1428-38.

Allain H., Bentue-Ferrer D., Tribut O., Gauthier S., Michel B. F., Drieu-La Rochelle C. (2003). Alzheimer's disease: the pharmacological pathway, Fundam Clin Pharmacol , 17 (4 ), 419-28.

Bhardwaj S. K., Beaudry G., Quirion R., Levesque D., Srivastava L. (2003). Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum, Neuroscience , 122 (3 ), 669-76.

Brouillette Jonathan, O'Donnell James, Díaz-Ruiz Oscar, Godbout Roger, Quirion R. (2003). Hippocampal Gene Expression Profiles in Memory-Impaired and Memory-Unimpaired Aged Rats, Brain Aging , 3 (4 ), 21-28.

Champagne D., Pearson D., Dea D., Rochford J., Poirier J. (2003). The cholesterol-lowering drug Probucol increases apolipoprotein e production in the hippocampus of aged rats: implications for Alzheimer's disease, Neuroscience , 121 (1 ), 99-110.

Danik M., Puma C., Quirion R., Williams S. (2003). Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, GABAergic, and cholinergic neurons and astrocytes of the rat brain: A single-cell reverse transcription-multiplex polymerase chain reaction study, J Neurosci Res , 74 (2 ), 286-95.

Degroot A., Kornecook T., Quirion R., DeBow S., Parent M. B. (2003). Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors, Brain Res , 979 (1-2 ), 71-7.

Desrosiers R. R., Bertrand Y., Nguyen Q. T., Demeule M., Gabathuler R., Kennard M. L., Gauthier S., Beliveau R. (2003). Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease, Biochem J , 374 (Pt 2 ), 463-71.

Dumont Y., Thakur M., Beck-Sickinger A., Fournier A., Quirion R. (2003). Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [(, Br J Pharmacol , 139 (7 ), 1360-1368.

Feldman H., Gauthier S., Hecker J., Vellas B., Emir B., Mastey V., Subbiah P., The Donepezil MSAD Study Investigators Group (2003). Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer`s disease, and the impact on caregiver burden, J Am Geriatr Soc , 51 , 737-744.

Feldman H., Levy A. R., Hsiung G. Y., Peters K. R., Donald A., Black S. E., Bouchard R. W., Gauthier S., Guzman D. A., Hogan D. B., Kertesz A., Rockwood K. (2003). A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results, Neuroepidemiology , 22 (5 ), 265-74.

Gauthier S. (2003). Clinical aspects of Alzheimer's disease . In Mulligan R., Van de Linden M., Juillerat A.C. & Mulligan R. (Eds.) , Clinical management of early Alzheimer's disease (pp. 21-34). Lawrence Erlbaum Associates, Inc..

Gauthier S. (2003). Management of later stages of Alzheimer’s disease . In Vellas B., Winblad B., Grundman M., Fitten L. J., Feldman H., Giacobini E., Kurz A. & Vellas B. (Eds.) , Research and Practice in Alzheimer's Disease (pp. 146-149). F.A. Davis.

Gauthier S., Emre M., Farlow M. R., Bullock R., Grossberg G. T., Potkin S. G. (2003). Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors, Curr Med Res Opin , 19 (8 ), 707-14.

Gauthier S., Joober R., Mottron L., Laurent S. B., Fuchs M., De Kimpe V., Rouleau G. A. (2003). Mutation screening of FOXP2 in individuals diagnosed with autistic disorder, Am J Med Genet , 118A (2 ), 172-5.